News Formal

Visa faces expanded debit card probe from Federal Trade Commission: Report - San Francisco Business Times

  • 📰 SFBusinessTimes
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 68%

United States News News

United States United States Latest News,United States United States Headlines

Visa and Mastercard say security tokens make card transactions safer. The FTC wonders if it also serves to safeguard those companies' dominant positions.

, widening a probe that's looking at whether the San Francisco company and fellow card giant Mastercard are putting up roadblocks to keep rival payments networks from processing debit card transactions.

The token is provided by the company whose name is on the card, so it’s most often Visa or Mastercard. If the token can only be understood and correctly linked to a card by the company that provided it, it means the payment moves most seamlessly over that company’s network. Critics of the companies say that entrenches the duo's dominant position over smaller, rival payment networks and restricts merchants from sending payments over other networks.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 78. in US

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Kidder Mathews names David Nelson to oversee Northern California offices - San Francisco Business TimesThe new executive has served in Bay Area real estate for 18 years.
Source: SFBusinessTimes - 🏆 78. / 68 Read more »

Nektar, PureTech Health pull plug on merger talks - San Francisco Business TimesNektar cut about 500 jobs and decided to sublease 200,000 square feet in San Francisco after a promising cancer drug failed clinical trials earlier this year.
Source: SFBusinessTimes - 🏆 78. / 68 Read more »